Changes

Jump to navigation Jump to search
33 bytes added ,  13:52, 2 August 2022
no edit summary
Line 1: Line 1:  
* Currently there are only three medications approved by the US Food and Drug Administration (FDA) for use via the intrathecal route:
 
* Currently there are only three medications approved by the US Food and Drug Administration (FDA) for use via the intrathecal route:
** morphine
+
** [[Opioids|Morphine]]
** ziconotide (best for neuropathic pain, but has narrow therapeutic window)
+
** Ziconotide (best for neuropathic pain, but has narrow therapeutic window)
** baclofen (for spasticity)
+
** [[Muscle Relaxants|Baclofen]] (for spasticity)
 
* Trials should be infusions, not bolus.
 
* Trials should be infusions, not bolus.

Navigation menu